We report the molecular basis for the differences in activity of cyclic and linear antimicrobial peptides. We iteratively performed atomistic molecular dynamics simulations and biophysical measurements to probe the interaction of a cyclic antimicrobial peptide and its inactive linear analogue with model membranes. We establish that, relative to the linear peptide, the cyclic one binds stronger to negatively charged membranes. We show that only the cyclic peptide folds at the membrane interface and adopts a beta-sheet structure characterised by two turns. Subsequently, the cyclic peptide penetrates deeper into the bilayer while the linear peptide remains essentially at the surface. Finally, based on our comparative study, we propose a model ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
A strategy for the design of antimicrobial cyclic peptides derived from the lead compounds c(KKLKKFK...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
AbstractWe report the molecular basis for the differences in activity of cyclic and linear antimicro...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
AbstractThe mechanism of action of antimicrobial peptides is, to our knowledge, still poorly underst...
This PhD thesis is the result of the combination of experimental and computational techniques with t...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
A strategy for the design of antimicrobial cyclic peptides derived from the lead compounds c(KKLKKFK...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
AbstractWe report the molecular basis for the differences in activity of cyclic and linear antimicro...
We report the molecular basis for the differences in activity of cyclic and linear antimicrobial pep...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
AbstractThe mechanism of action of antimicrobial peptides is, to our knowledge, still poorly underst...
This PhD thesis is the result of the combination of experimental and computational techniques with t...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...
A strategy for the design of antimicrobial cyclic peptides derived from the lead compounds c(KKLKKFK...
The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To ...